{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:34:40Z","timestamp":1760661280646,"version":"build-2065373602"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejca.2025.115334","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T11:26:44Z","timestamp":1741001204000},"page":"115334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The 2024 State of Science report from the European Organisation for Research and Treatment of Cancer\u2019s Radiation Oncology Scientific Council"],"prefix":"10.1016","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8392-3252","authenticated-orcid":false,"given":"Daniel","family":"Portik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Lacombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5374-8851","authenticated-orcid":false,"given":"V\u00e9rane","family":"Achard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolaus","family":"Andratschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1099-9009","authenticated-orcid":false,"given":"Dora","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3960-7673","authenticated-orcid":false,"given":"Mateusz","family":"Spalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2203-4848","authenticated-orcid":false,"given":"Piet","family":"Ost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6177-1755","authenticated-orcid":false,"given":"Felix","family":"Ehret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2025.115334_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1470-2045(23)00182-1","article-title":"Global funding for cancer research between 2016 and 2020: a content analysis of public and philanthropic investments","volume":"24","author":"McIntosh","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamaoncol.2020.7478","article-title":"An analysis of contemporary oncology randomized clinical trials from low\/middle-income vs high-income countries","volume":"7","author":"Wells","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib3","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(19)30794-6","article-title":"How public health services pay for radiotherapy in Europe: an ESTRO\u2013HERO analysis of reimbursement","volume":"21","author":"Lievens","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2020.01.024","article-title":"The financial impact of SBRT for oligometastatic disease: a population-level analysis in Belgium","volume":"145","author":"Nevens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2019.03.031","article-title":"Radiation oncology. optimal health for all, together. ESTRO vision, 2030","volume":"136","author":"Lievens","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib7","first-page":"827","article-title":"Global radiotherapy","author":"Abdel-wahab","year":"2021","journal-title":"Curr Status Future Dir \u2014 White Pap Abstr"},{"key":"10.1016\/j.ejca.2025.115334_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2020.02.050","article-title":"ScienceDirect The European organisation for research and treatment of cancer, state of science in radiation oncology and priorities for clinical trials meeting report","volume":"131","author":"Thomas","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib9","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1470-2045(23)00319-4","article-title":"Common sense oncology: outcomes that matter","volume":"24","author":"Booth","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2017.12.009","article-title":"Concurrent chemoradiotherapy for bladder cancer: practice patterns and outcomes in the general population","volume":"127","author":"Ghate","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib11","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1245\/s10434-022-12133-8","article-title":"Does breast-conserving surgery with radiotherapy have a better survival than mastectomy? a meta-analysis of more than 1,500,000 patients","volume":"29","author":"De La Cruz Ku","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41575-024-00900-9","article-title":"Future direction of total neoadjuvant therapy for locally advanced rectal cancer","volume":"21","author":"Kagawa","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2025.115334_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082873","article-title":"Watch and wait approach for rectal cancer","volume":"12","author":"Cerdan-Santacruz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejca.2025.115334_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma the ORATOR2 Phase 2 randomized clinical trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","article-title":"Radiation therapy for brain metastases: an ASTRO clinical practice guideline","volume":"12","author":"Gondi","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib18","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care?","volume":"363","author":"Pm","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115334_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.lungcan.2020.05.003","article-title":"Effects of an exercise intervention for patients with advanced inoperable lung cancer undergoing chemotherapy: a randomized clinical trial","volume":"145","author":"Quist","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.934369","article-title":"Role of real-world data in assessing cardiac toxicity after lung cancer radiotherapy","volume":"12","author":"Abravan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36149","article-title":"Participation of older adults in clinical trials for new drug applications and biologics license applications from 2010 through 2019","volume":"5","author":"Lau","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejca.2025.115334_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43856-022-00156-x","article-title":"Patient involvement in clinical trials","volume":"2","author":"Gei\u00dfler","year":"2022","journal-title":"Commun Med"},{"key":"10.1016\/j.ejca.2025.115334_bib23","first-page":"1","article-title":"Patients\u2019 knowledge, preferences, and perspectives about data protection and data control: an exploratory survey","volume":"14","author":"Lalova-Spinks","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ejca.2025.115334_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(21)00233-6","article-title":"Contemporary radiotherapy: present and future","volume":"398","author":"Chandra","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115334_bib25","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrc.2016.18","article-title":"Radiation oncology in the era of precision medicine","volume":"16","author":"Baumann","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib26","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ad4192","article-title":"Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps","volume":"69","author":"Prezado","year":"2024","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejca.2025.115334_bib27","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib28","article-title":"Lattice radiation therapy in clinical practice: a systematic review","volume":"39","author":"Iori","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2023.12.013","article-title":"Overview and recommendations for prospective multi-institutional spatially fractionated radiation therapy clinical trials","volume":"119","author":"Li","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","article-title":"AI in health and medicine","volume":"28","author":"Rajpurkar","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2025.115334_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0959-8049(02)00113-2","article-title":"The quality assurance programme of the radiotherapy group of the european organization for research and treatment of cancer (EORTC): a critical appraisal of 20 years of continuous efforts","volume":"39","author":"Kouloulias","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib32","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1016\/S1470-2045(23)00625-3","article-title":"Radiotherapy trial quality assurance processes: a systematic review","volume":"25","author":"Brooks","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib33","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive radiation therapy (ART) strategies and technical considerations: a state of the ART review From NRG oncology","volume":"109","author":"Glide-Hurst","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib34","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/0284186X.2018.1505053","article-title":"Adaptive radiotherapy for head and neck cancer","volume":"57","author":"Castelli","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.637591","article-title":"MR-guided adaptive radiotherapy for bladder cancer","volume":"11","author":"Hijab","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib36","article-title":"An international consensus on the design of prospective clinical\u2013translational trials in spatially fractionated radiation therapy","volume":"7","author":"Mayr","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2020.09.008","article-title":"Overview of artificial intelligence-based applications in radiotherapy: recommendations for implementation and quality assurance","volume":"153","author":"Vandewinckele","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jrr\/rrae033","article-title":"Applications of artificial intelligence for machine- and patient-specific quality assurance in radiation therapy: current status and future directions","volume":"65","author":"Ono","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ejca.2025.115334_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2020.09.008","article-title":"Overview of artificial intelligence-based applications in radiotherapy: recommendations for implementation and quality assurance","volume":"153","author":"Vandewinckele","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3390\/cancers14153625","article-title":"Should peak dose be used to prescribe spatially fractionated radiation therapy?\u2014a review of preclinical studies","volume":"14","author":"Fernandez-Palomo","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2025.115334_bib41","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.soc.2023.02.006","article-title":"Biology-guided radiation therapy: an evolving treatment paradigm","volume":"32","author":"Ladbury","year":"2023","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejca.2025.115334_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1080\/0284186X.2019.1657587","article-title":"BIGART 2019\u2013adapting to the future","volume":"58","author":"Overgaard","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41416-019-0602-7","article-title":"Human papillomavirus as a driver of head and neck cancers","volume":"122","author":"Sabatini","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41568-018-0007-6","article-title":"Organoids in cancer research","volume":"18","author":"Drost","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216180","article-title":"Patient-derived organoids in translational oncology and drug screening","volume":"562","author":"Yang","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2025.115334_bib46","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"HHS public access to chemoradiation","volume":"25","author":"Ganesh","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ejca.2025.115334_bib47","first-page":"1","article-title":"Advances of patient-derived organoids in personalized radiotherapy","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib48","doi-asserted-by":"crossref","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"Lesavage","year":"2022","journal-title":"Nat Mater"},{"key":"10.1016\/j.ejca.2025.115334_bib49","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2018.04.055","article-title":"Imaging of tumor characteristics and molecular pathways with PET: developments over the last decade toward personalized cancer therapy","volume":"102","author":"Marcu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib50","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ijrobp.2010.10.029","article-title":"Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion","volume":"82","author":"Janssen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib51","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.sult.2010.10.001","article-title":"Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy","volume":"31","author":"Kinahan","year":"2010","journal-title":"Semin Ultrasound CT MRI"},{"key":"10.1016\/j.ejca.2025.115334_bib52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1158\/1078-0432.CCR-21-3143","article-title":"Meta-analysis of the test\u2013retest repeatability of [18F]-fluorodeoxyglucose standardized uptake values: implications for assessment of tumor response","volume":"29","author":"Shankar","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.115334_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminoncol.2019.07.001","article-title":"PET\/CT in radiation oncology","volume":"46","author":"Fonti","year":"2019","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib54","doi-asserted-by":"crossref","first-page":"LBA8069","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA8069","article-title":"Overall survival following heterogeneous FDG-guided dose-escalation for locally advanced NSCLC in the international phase III NARLAL2 trial","volume":"42","author":"Schytte","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib55","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.24.00022","article-title":"Primary results of NRG-RTOG1106\/ECOG-ACRIN 6697: a randomized Phase II trial of individualized adaptive (chemo) radiotherapy using midtreatment 18F-fluorodeoxyglucose position emission tomography\/computed tomography in Stage III non-small cell lung cancer","author":"Kong","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib56","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/SPC.0000000000000533","article-title":"Methods for frailty screening and geriatric assessment in older adults with cancer","volume":"15","author":"Puts","year":"2021","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.ejca.2025.115334_bib57","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/S1470-2045(18)30348-6","article-title":"Functional versus chronological age: geriatric assessments to guide decision making in older patients with cancer","volume":"19","author":"Soto-Perez-de-Celis","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2018.04.013","article-title":"Predicting early death in older adults with cancer","volume":"100","author":"Boulahssass","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib59","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.clon.2020.09.002","article-title":"Impaired geriatric 8 score is associated with worse survival after radiotherapy in older patients with cancer","volume":"33","author":"Middelburg","year":"2021","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib60","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jcsm.12526","article-title":"Handgrip weakness, low fat-free mass, and overall survival in non-small cell lung cancer treated with curative-intent radiotherapy","volume":"11","author":"Burtin","year":"2020","journal-title":"J Cachex-- Sarcopenia Muscle"},{"key":"10.1016\/j.ejca.2025.115334_bib61","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.ijrobp.2020.11.045","article-title":"The Dutch\u2013Belgian registry of stereotactic body radiation therapy for liver metastases: clinical outcomes of 515 patients and 668 metastases","volume":"109","author":"M\u00e9ndez Romero","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.semradonc.2017.02.002","article-title":"Advances in stereotactic body radiation therapy for hepatocellular carcinoma","volume":"27","author":"Murray","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib63","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2023.08.015","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: meta-analysis and international stereotactic radiosurgery society practice guidelines","volume":"118","author":"Bae","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib64","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ijrobp.2022.06.084","article-title":"A critical review of the role of local therapy for oligometastatic gastrointestinal cancer","volume":"114","author":"Jethwa","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib65","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1470-2045(24)00020-2","article-title":"Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial","volume":"25","author":"Siva","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib66","doi-asserted-by":"crossref","first-page":"140","DOI":"10.5114\/wo.2021.107689","article-title":"Noninvasive celiac plexus radiosurgery in palliative treatment for patients with symptomatic pancreatic cancer","volume":"25","author":"Miszczyk","year":"2021","journal-title":"Wspolczesna Onkol"},{"key":"10.1016\/j.ejca.2025.115334_bib67","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijrobp.2022.02.038","article-title":"Single-fraction celiac plexus radiosurgery: a preliminary proof-of-concept Phase 2 clinical trial","volume":"113","author":"Hammer","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib68","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2025.115334_bib69","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET Phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2024.110235","article-title":"Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: an interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study","volume":"195","author":"Christ","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2025.115334_bib72","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.ijrobp.2024.06.033","article-title":"Ablative radiation therapy to restrain everything safely treatable (ARREST): a phase 1 study of stereotactic ablative radiation therapy for polymetastatic disease","volume":"120","author":"Nguyen","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2025.115334_bib73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00066-018-01422-5","article-title":"Combination of stereotactic radiotherapy and targeted therapy: patterns-of-care survey in German-speaking countries","volume":"195","author":"Kroeze","year":"2019","journal-title":"Strahlenther Und Onkol"},{"key":"10.1016\/j.ejca.2025.115334_bib74","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC\u2013ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2025.115334_bib75","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"Nicholas Van","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2025.115334_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103228","article-title":"Radiation treatment for adult rare cancers: oldest and newest indication","volume":"159","author":"Fiorentino","year":"2021","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925001157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925001157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T18:46:52Z","timestamp":1760640412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925001157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":76,"alternative-id":["S0959804925001157"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115334","relation":{},"ISSN":["0959-8049"],"issn-type":[{"type":"print","value":"0959-8049"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2024 State of Science report from the European Organisation for Research and Treatment of Cancer\u2019s Radiation Oncology Scientific Council","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115334"}}